US Stock MarketDetailed Quotes

SMMT Summit Therapeutics

Watchlist
  • 23.460
  • +1.620+7.42%
Close Oct 16 16:00 ET
  • 23.770
  • +0.310+1.32%
Post 20:01 ET
17.24BMarket Cap-213272P/E (TTM)

Summit Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Summit Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 6, 20242024/Q20.000 / 0.000--
May 1, 20242024/Q10.000 / 0.000--
--2021/Q3975.890K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 6, 20242024/Q20.000 / 0.000--
May 1, 20242024/Q10.000 / 0.000--
--2021/Q3975.890K / 0.000--

Unlock Free Earnings Estimates

Summit Therapeutics Earnings Reports

  • Summit Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 07:43 ET

  • Summit Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 1 08:14 ET

  • Summit Therapeutics | 10-K: FY2023 Annual Report

    Feb 20 07:38 ET

  • Summit Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 08:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 2, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data